The first series A tranche will help commercialise a remedy for metabolic disorders and inflammatory conditions resulting from cardio-metabolic problems.

Harvard University has spun out NuProbe to commercialise a molecular blood test based on research by Peng Yin and David Zhang at the Wyss Institute.

The government-owned Scottish Investment Bank has returned to pour more funding into Strathclyde mycoprotein spinout 3F Bio.

Urbix Resources was formed to commercialise research into manufacturing graphene conducted at University of Arizona.

KPCB and affiliates have supplied a $35m series A extension for University of Pennsylvania spinout Tmunity, after the institution backed a $100m close in January.

IP Group has committed a total of $6.6m to a series A round for Enterprise Therapeutics, which had previously attracted capital from Touchstone Innovations.

Partially based on research at Duke University, Camras Vision is working on a treatment for refractory glaucoma.

The commercialisation firm has invested $3.5m in Orbital Sidekick and another $4m in TableUp.

UC's Office of the Chief Investment Officer has backed a new immuno-oncology startup that has licensed 17 assets from Pfizer.